Clinical Study of Decalcification Bone Scaffold for Cartilage Lesions of the Knee
Not Applicable
- Conditions
- Cartilage Injury
- Interventions
- Procedure: decalcification bone scaffoldProcedure: microfracture
- First Posted Date
- 2017-10-26
- Last Posted Date
- 2020-07-02
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT03321812
- Locations
- 🇨🇳
Institute of Sports Medicine, Beijing, Beijing, China
Lung and Gut Microbiome in Chronic Obstructive Pulmonary Disease
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2017-10-16
- Last Posted Date
- 2017-10-16
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT03310164
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Suspended Overlength Biliary Stents Preventing Duodenobiliary Reflux in Patients With Biliary Stricture
Not Applicable
- Conditions
- Bile Duct Stricture
- Interventions
- Procedure: ordinary plastic biliary stentsProcedure: 26cm suspended overlength biliary stentsProcedure: 30cm suspended overlength biliary stents
- First Posted Date
- 2017-10-16
- Last Posted Date
- 2021-08-11
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 117
- Registration Number
- NCT03310554
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Relationship Between Metabolic Profile and Clinical Phenotype in Chronic Obstructive Pulmonary Disease
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2017-10-16
- Last Posted Date
- 2017-10-17
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 167
- Registration Number
- NCT03310177
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Mixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Large Esophageal Carcinoma
Not Applicable
Completed
- Conditions
- Esophageal Stenosis Acquired
- Interventions
- Other: Hydrocortisone sodium succinate mixed with Aluminium Phosphate gel (route of administration)Other: Triamcinolone Acetonide (route of administration)Other: Prednisone (route of administration)
- First Posted Date
- 2017-05-24
- Last Posted Date
- 2021-01-20
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 66
- Registration Number
- NCT03165344
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Contrast-enhanced Ultrasound-guided Fine-needle Aspiration Biopsy in the Evaluation of Thyroid Nodules
- Conditions
- Thyroid Nodules
- Interventions
- Procedure: conventional ultrasound groupProcedure: contrast-enhanced ultrasound group
- First Posted Date
- 2017-04-05
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT03102099
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Prevention of Ulinastatin on Acute Respiratory Distress Syndrome (ARDS)
Not Applicable
Completed
- Conditions
- Acute Respiratory Distress SyndromeCritical Illness
- Interventions
- Drug: UlinastatinOther: Usual care
- First Posted Date
- 2017-03-24
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 840
- Registration Number
- NCT03089957
- Locations
- 🇨🇳
Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing, Beijing, China
🇨🇳Central Hospital of Zi Bo, Zibo, Shandong, China
🇨🇳CANGZHOU People's Hospital, Cangzhou, Hebei, China
Management and Treatment of Patients With Severe Malnutrition in Intensive Care Unit: a Registry
- Conditions
- Severe Malnutrition
- Interventions
- Other: management of severe malnutrition
- First Posted Date
- 2017-02-16
- Last Posted Date
- 2017-02-16
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT03055104
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
Phase 1
- Conditions
- Nonsmall Cell Lung Cancer
- Interventions
- Drug: Apatinib Mesylate TabletsDrug: EGFR-TKIs (Erlotinib, Gefitinib and Osimertinib)
- First Posted Date
- 2017-02-10
- Last Posted Date
- 2017-02-10
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03050411
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Associations Between Air Pollutants Exposures and Respiratory System Study
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2016-11-15
- Last Posted Date
- 2016-11-15
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 106
- Registration Number
- NCT02964117
© Copyright 2025. All Rights Reserved by MedPath